Arena Pharmaceuticals' (ARNA) CEO Amit Munshi on Q3 2020 Results - Earnings Call TranscriptSeeking Alpha • 11/10/20
Arena Reports Third Quarter Financial Results with Strong Cash Position, Advancing Etrasimod Into a Phase 3 Registrational Program in Atopic DermatitisPRNewsWire • 11/09/20
Arena Pharmaceuticals Advancing Etrasimod Into Phase 3 Program in Atopic Dermatitis (AD), Reports Compelling Topline Results from Phase 2b ADVISE TrialPRNewsWire • 11/09/20
Arena Pharmaceuticals' Presence at United European Gastroenterology Week Strengthens Ongoing Commitment to the Gastrointestinal Disease CommunityPRNewsWire • 10/09/20
Arena Pharmaceuticals, Inc. (ARNA) CEO Amit Munshi Presents at Jefferies Next Generation IBD Therapeutics Virtual Summit Call TranscriptSeeking Alpha • 09/23/20
Arena Pharmaceuticals, Inc. (ARNA) CEO Amit Munshi Presents at Cantor 2020 Global Virtual Healthcare Conference (Transcript)Seeking Alpha • 09/16/20
Arena Pharmaceuticals, Inc.'s (ARNA) CEO Amit Munshi at Wells Fargo Securities 2020 Virtual Healthcare Conference (Transcript)Seeking Alpha • 09/10/20
Arena Pharmaceuticals, Inc. (ARNA) CEO Amit Munshi on Q2 2020 Results - Earnings Call TranscriptSeeking Alpha • 08/06/20
Arena Pharmaceuticals Announces Completion of Public Offering of Common Stock and Exercise in Full of Underwriters' Option to Purchase Additional SharesPRNewsWire • 06/01/20